Global Cord Blood (NYSE:CO) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO) in a report released on Sunday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Price Performance

Shares of NYSE CO opened at $1.26 on Friday. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50. The company has a market cap of $153.15 million, a PE ratio of 1.97 and a beta of 0.16. The business’s 50 day moving average price is $1.46 and its two-hundred day moving average price is $1.40.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.